4729-37-12 Dangerous drug monitoring.

Pursuant to section 4729.75 of the Revised Code, the required information for the following list of drugs pursuant to an outpatient prescription, personally furnished by a prescriber, or sold at wholesale to a prescriber or a terminal distributor of dangerous drugs shall be submitted to the state board of pharmacy in accordance with sections 4729.77, 4729.78 and 4729.79 of the Revised Code:

All dangerous drug products containing gabapentin.

Cite as Ohio Admin. Code 4729-37-12

Effective: 12/1/2016
Five Year Review (FYR) Dates: 12/01/2021
Promulgated Under: 119.03
Statutory Authority: 3719.28 , 4729.26 , 4729.84
Rule Amplifies: 4729.75 , 4729.76 , 4729.77 , 4729.78 , 4729.79 , 4729.80 , 4729.81 , 4729.82 , 4729.83 , 4729.84